Lipid and Metabolic Syndromes

Metabolic syndrome is the major cause that contribute to cardiovascular morbidity and mortality. It is a cluster of metabolic disorders, such as dyslipidemia, abdominal obesity, hypertension and impaired fasting glucose which will increase the risk for cardiovascular disease. The dietary lipids are also recognized to contribute in the development and the prevention of cardiovascular risk clustering. This review explores the relevant mechanisms involved in the influence of dietary fatty acids on metabolic syndrome components.

The development of metabolic syndrome mainly due to Genetics and the environmental factors. Approximately 20%-30% of the population in industrialized countries has metabolic syndrome and the people with Metabolic syndrome will have three times higher risk of developing cardiovascular disease. Additionally, statin drugs play a key role in the treatment of people with coronary heart disease, mostly because they lower LDL cholesterol.

The treatment choices include changing lifestyle and weight reduction which usually requires a specifically tailored, multifaceted program that includes diet and exercise. Medications also may be useful.

  • High blood cholesterol
  • Diabetes
  • Stress and hypertension
  • Obesity and overweight
  • Smoking and alcohol
  • Physical inactivity
  • Heredity and gender
  • Age and sex hormones
  • Cardiovascular epidemiology

Related Conference of Lipid and Metabolic Syndromes

August 27-28, 2026

40th European Cardiology Conference

Berlin, Germany
October 20-21, 2026

15th World Heart Congress

London, UK
October 22-23, 2026

34th International Congress on Cardiology and Medical Interventions

Toronto, Canada
November 09-10, 2026

9th Global Cardiovascular Research and Clinical Cardiology

Paris, France
November 09-10, 2026

7th Annual Summit on Cardiology and Heart Diseases

Paris, France
November 16-17, 2026

36th International Conference on Cardiology and Healthcare

Tokyo, Japan
November 16-17, 2026

37th International Conference on Cardiology and Heart Failure

Tokyo, Japan
November 16-17, 2026

8th World Heart Congress

Tokyo, Japan
November 23-24, 2026

40th World Congress on Heart Diseases

Toronto, Canada
November 25-26, 2026

33rd World Heartcare Summit

Paris, France
December 17-18, 2026

13th World Congress on Hypertension, Cardiology, Primary Health and Patient Care

Paris, France
January 26-27, 2027

12th International Heart Conference

Dubai, UAE
March 18-19, 2027

16th World Heart Congress

Paris, France
March 23-24, 2027

14th International Conference on Geriatric Cardiology, Cardiovascular Diseases and Palliative Care

Paris, France
May 13-14, 2027

10th Annual Heart Rhythm Conference

Rome, Italy
May 13-14, 2027

6th Global Summit on Cardiology and Cardiac Surgery

Rome, Italy
June 17-18, 2027

10th World Heart and Brain Conference

London, UK
June 21-22, 2027

8th European Summit on Cardiology Research

Zurich, Switzerland
June 29-30, 2027

35th International Conference on Clinical and Experimental Cardiology Research

Toronto, Canada

Lipid and Metabolic Syndromes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in